抗血小板治疗的最新进展

被引：13

作者：

蔡琳

邓晓奇

燕纯伯

机构：

[1] 成都市第三人民医院成都市心血管病研究所

来源：

心血管病学进展 | 2009年 / 30卷 / 01期

关键词：

抗血小板药物; 阿司匹林; 噻吩吡啶类药; 血小板膜糖蛋白受体拮抗剂; 西洛他唑; 普拉格雷;

D O I：

暂无

中图分类号：

R54 [心脏、血管（循环系）疾病]; R743 [脑血管疾病];

学科分类号：

1002 ; 100201 ;

摘要：

大量临床研究已证实抗血小板药物:阿司匹林、噻吩吡啶类药物、血小板膜糖蛋白受体拮抗剂、西洛他唑等在预防和治疗心脑血管疾病以及外周动脉血管病变中具有十分重要的作用。洞悉药物的作用机理、应用现状、进展和存在的争议,对于更好地运用该类药物具有十分重要的作用。现就相关内容进行简要综述。

引用

页码：102 / 105

页数：4

共 6 条

[1]

Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38[J] . Stephen D. Wiviott,Eugene Braunwald,Dominick J. Angiolillo,Simha Meisel,Anthony J. Dalby,Freek W.A. Verheugt,Shaun G. Goodman,Ramon Corbalan,Drew A. Purdy,Sabina A. Murphy,Carolyn H. McCabe,Elliott M. Antman.Circulation . 2008

[2]

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study （Cilostazol: A Study in Long-term Effects）[J] . William R. Hiatt,Samuel R. Money,Eric P. Brass.Journal of Vascular Surgery . 2008 (2)

[3]

Prasugrel Compared With High Loading– and Maintenance–Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 Trial[J] . Circulation . 2007 (25)

[4]

Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: Results from the Cilostazol for RESTenosis （CREST） trial[J] . Zefeng Zhang,Jovonne K. Foster,Paul Kolm,Claudine T. Jurkovitz,Karen M. Parker,Nancy V. Murrah,Grant T. Anderson,John S. Douglas,William S. Weintraub.American Heart Journal . 2006 (4)

[5] Coronary stent restenosis in patients treated with cilostazol [J].

Douglas, JS ;

Holmes, DR ;

Kereiakes, DJ ;

Grines, CL ;

Block, E ;

Ghazzal, ZMB ;

Morris, DC ;

Liberman, H ;

Parker, K ;

Jurkovitz, C ;

Murrah, N ;

Foster, J ;

Hyde, P ;

Mancini, GBJ ;

Weintraub, WS .

CIRCULATION, 2005, 112 (18) :2826-2832

[6]

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events （CAPRIE）[J] . The Lancet . 1996 (9038)

← 1 →